Following its initial clearance in the Continent , ACE-031 1mg is seeing promising interest . Sales figures indicate a increasing response among healthcare professionals , particularly in Germany . Challenges surrounding reimbursement remain, and are currently being addressed by the developer through planned discussions with health authorities. The